Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritin.

Yang X, Lee J, Mahony EM, Kwong PD, Wyatt R, Sodroski J.

J Virol. 2002 May;76(9):4634-42.

PMID:
11932429
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteins.

Yang X, Farzan M, Wyatt R, Sodroski J.

J Virol. 2000 Jun;74(12):5716-25.

PMID:
10823881
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Soluble mimetics of human immunodeficiency virus type 1 viral spikes produced by replacement of the native trimerization domain with a heterologous trimerization motif: characterization and ligand binding analysis.

Pancera M, Lebowitz J, Schön A, Zhu P, Freire E, Kwong PD, Roux KH, Sodroski J, Wyatt R.

J Virol. 2005 Aug;79(15):9954-69.

PMID:
16014956
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Processing, stability, and receptor binding properties of oligomeric envelope glycoprotein from a primary HIV-1 isolate.

Staropoli I, Chanel C, Girard M, Altmeyer R.

J Biol Chem. 2000 Nov 10;275(45):35137-45.

PMID:
10926931
[PubMed - indexed for MEDLINE]
Free Article
5.

A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.

Binley JM, Sanders RW, Clas B, Schuelke N, Master A, Guo Y, Kajumo F, Anselma DJ, Maddon PJ, Olson WC, Moore JP.

J Virol. 2000 Jan;74(2):627-43.

PMID:
10623724
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1.

Sanders RW, Vesanen M, Schuelke N, Master A, Schiffner L, Kalyanaraman R, Paluch M, Berkhout B, Maddon PJ, Olson WC, Lu M, Moore JP.

J Virol. 2002 Sep;76(17):8875-89.

PMID:
12163607
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solution.

Yang X, Florin L, Farzan M, Kolchinsky P, Kwong PD, Sodroski J, Wyatt R.

J Virol. 2000 May;74(10):4746-54.

PMID:
10775613
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein.

Schülke N, Vesanen MS, Sanders RW, Zhu P, Lu M, Anselma DJ, Villa AR, Parren PW, Binley JM, Roux KH, Maddon PJ, Moore JP, Olson WC.

J Virol. 2002 Aug;76(15):7760-76.

PMID:
12097589
[PubMed - indexed for MEDLINE]
Free PMC Article
10.
11.

HIV type 1 Env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies.

Chakrabarti BK, Pancera M, Phogat S, O'Dell S, McKee K, Guenaga J, Robinson J, Mascola J, Wyatt RT.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):877-87. doi: 10.1089/AID.2010.0281. Epub 2011 Jan 19.

PMID:
21158699
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

A functional interaction between gp41 and gp120 is observed for monomeric but not oligomeric, uncleaved HIV-1 Env gp140.

Guttman M, Lee KK.

J Virol. 2013 Nov;87(21):11462-75. doi: 10.1128/JVI.01681-13. Epub 2013 Aug 21.

PMID:
23966389
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.

Doranz BJ, Baik SS, Doms RW.

J Virol. 1999 Dec;73(12):10346-58.

PMID:
10559353
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Biochemically defined HIV-1 envelope glycoprotein variant immunogens display differential binding and neutralizing specificities to the CD4-binding site.

Feng Y, McKee K, Tran K, O'Dell S, Schmidt SD, Phogat A, Forsell MN, Karlsson Hedestam GB, Mascola JR, Wyatt RT.

J Biol Chem. 2012 Feb 17;287(8):5673-86. doi: 10.1074/jbc.M111.317776. Epub 2011 Dec 13.

PMID:
22167180
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Analysis of the neutralizing antibody response elicited in rabbits by repeated inoculation with trimeric HIV-1 envelope glycoproteins.

Grundner C, Li Y, Louder M, Mascola J, Yang X, Sodroski J, Wyatt R.

Virology. 2005 Jan 5;331(1):33-46.

PMID:
15582651
[PubMed - indexed for MEDLINE]
Free Article
16.
17.
18.

Promoting trimerization of soluble human immunodeficiency virus type 1 (HIV-1) Env through the use of HIV-1/simian immunodeficiency virus chimeras.

Center RJ, Lebowitz J, Leapman RD, Moss B.

J Virol. 2004 Mar;78(5):2265-76.

PMID:
14963123
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Conserved structures exposed in HIV-1 envelope glycoproteins stabilized by flexible linkers as potent entry inhibitors and potential immunogens.

Chow YH, Wei OL, Phogat S, Sidorov IA, Fouts TR, Broder CC, Dimitrov DS.

Biochemistry. 2002 Jun 4;41(22):7176-82.

PMID:
12033952
[PubMed - indexed for MEDLINE]
20.

Trimeric HIV-1 glycoprotein gp140 immunogens and native HIV-1 envelope glycoproteins display the same closed and open quaternary molecular architectures.

Harris A, Borgnia MJ, Shi D, Bartesaghi A, He H, Pejchal R, Kang YK, Depetris R, Marozsan AJ, Sanders RW, Klasse PJ, Milne JL, Wilson IA, Olson WC, Moore JP, Subramaniam S.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11440-5. doi: 10.1073/pnas.1101414108. Epub 2011 Jun 27.

PMID:
21709254
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk